Trial Profile
A phase 2, open-label, multi-center study to assess efficacy, safety and pharmacokinetics of a tacrolimus new oral formulation (MR4) in de novo bone marrow transplant recipients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Sep 2006
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Graft-versus-host disease
- Focus Pharmacokinetics; Therapeutic Use
- 27 Sep 2006 Status change
- 14 Nov 2005 New trial record.